KORU Medical (KRMD) CEO adds 1,191 shares in open-market buy

Rhea-AI Filing Summary

KORU Medical Systems, Inc. CEO Linda M. Tharby bought additional company stock in the open market. On May 15, 2026, she purchased 1,191 shares of Common Stock at $3.92 per share. After this transaction, she directly owned 620,622 shares of KORU Medical common stock.

Insider Trade Summary

Net Buyer: 1,191 shares ($4,669)

Net Buy 1 txn

Insider Tharby Linda M

Role Chief Executive Officer

Bought 1,191 shs ($5K)

Type	Security	Shares	Price	Value
Purchase	Common Stock	1,191	$3.92	$5K

Holdings After Transaction: Common Stock — 620,622 shares (Direct, null)

Footnotes (1)

Key Figures

Shares purchased: 1,191 shares Purchase price: $3.92 per share Shares owned after transaction: 620,622 shares +1 more

4 metrics

Shares purchased 1,191 shares Open-market purchase on May 15, 2026

Purchase price $3.92 per share Price paid for KRMD Common Stock

Shares owned after transaction 620,622 shares Direct holdings after May 15, 2026 trade

Net buy shares 1,191 shares Net change in non-derivative holdings from this filing

Key Terms

Common Stock, open-market purchase, Chief Executive Officer, Form 4/A

4 terms

Common Stock financial

"security_title: "Common Stock""

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

open-market purchase financial

"transaction_action: "open-market purchase""

An open-market purchase is when an investor or a company buys shares on a public stock exchange at the going market price, rather than through a private deal. It matters to investors because these purchases change how many shares are available, can push the stock price up or signal confidence from large buyers, and often affect per-share metrics like earnings—think of it like someone buying lots of apples off a grocery shelf, reducing supply and potentially raising the price.

Chief Executive Officer financial

"officer_title: "Chief Executive Officer""

A chief executive officer (CEO) is the top leader of a company, responsible for making major decisions, setting goals, and guiding the organization’s overall direction. Think of the CEO as the captain of a ship, steering it toward success. Investors pay close attention to the CEO because their leadership and strategy can significantly influence the company's performance and future growth.

Form 4/A regulatory

"form_type: "4/A""

Form 4/A is an amended filing that corrects or updates an earlier Form 4, the mandatory report that insiders (like company executives, directors, or large shareholders) must file when their ownership stakes change. Think of it as an edited receipt showing who bought or sold stock and when; investors use it to track insider confidence, detect potential conflicts, and spot trading patterns that might signal future company prospects.

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Tharby Linda M

(Last) (First) (Middle)

C/O KORU MEDICAL SYSTEMS, INC.

100 CORPORATE DRIVE

(Street)

MAHWAH NEW JERSEY 07430

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
KORU Medical Systems, Inc. [ KRMD ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Executive Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/15/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)
05/20/2026

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	05/15/2026		P		1,191	A	$3.92	620,622	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

This Form 4/A amendment filing corrects a typographical error found on the original Form 4 filing in Table I, Box 4, Price. The correct price per share is $3.92. The filing of this statement shall not be construed as an admission (a) that the person filing this statement is, for the purposes of Section 16 of the Securities Exchange Act of 1934, as amended, the beneficial owner of any equity securities covered by this statement, or (b) that this statement is legally required to be filed by such person. Power of Attorney has been previously filed.

	/s/ Thomas Adams - Attorney-in-Fact	05/20/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did KRMD CEO Linda Tharby report on May 15, 2026?

KRMD CEO Linda M. Tharby reported an open-market purchase of 1,191 shares of KORU Medical Common Stock on May 15, 2026, at a price of $3.92 per share, increasing her directly held position.

How many KRMD shares does CEO Linda Tharby hold after this Form 4/A?

After the reported transaction, CEO Linda M. Tharby directly holds 620,622 shares of KORU Medical Common Stock. This figure reflects her position following the 1,191-share open-market purchase disclosed in the amended Form 4.

Was the KRMD CEO’s May 2026 transaction a purchase or a sale?

The May 2026 transaction by KRMD CEO Linda M. Tharby was a purchase. She executed an open-market buy of 1,191 shares of KORU Medical Common Stock at $3.92 per share, increasing her direct ownership stake.

What price did KRMD CEO Linda Tharby pay per share in the reported trade?

Linda M. Tharby paid $3.92 per share in the reported trade. The Form 4/A shows she bought 1,191 shares of KORU Medical Common Stock in the open market at this price, modestly raising her overall direct holdings.

Does the KRMD Form 4/A show any derivative securities activity for the CEO?

The Form 4/A data shows no derivative securities activity for the CEO. The derivativeSummary is empty, indicating the only reported transaction is the non-derivative open-market purchase of 1,191 shares of KORU Medical Common Stock.